Patent · US Active

Compound and pharmacologically acceptable salt thereof

US10669283B2 · kind B2 · utility

1Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 26, 2017
Grant dateJun 2, 2020
Priority date—
Expiry dateDec 26, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound represented by the general formula (1) below or a pharmacologically acceptable salt thereof: [In the formula (1),

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.